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Abstract
a-Synuclein is a key molecule in understanding the pathogenesis of neurodegenerative a-synucleinopathies such as
Parkinson’s disease. Despite extensive research, however, its precise function remains unclear partly because of a difficulty
in immunoblotting detection of endogenous a-synuclein. This difficulty has largely restricted the progress for a-
synucleinopathy research. Here, we report that a-synuclein monomers tend to easily detach from blotted membranes,
resulting in no or very poor detection. To prevent this detachment, a mild fixation of blotted membranes with
paraformaldehyde was applied to the immunoblotting method. Amazingly, this fixation led to clear and strong detection of
endogenous a-synuclein, which has been undetectable by a conventional immunoblotting method. Specifically, we were
able to detect endogenous a-synuclein in various human cell lines, including SH-SY5Y, HEK293, HL60, HeLa, K562, A375, and
Daoy, and a mouse cell line B16 as well as in several mouse tissues such as the spleen and kidney. Moreover, it should be
noted that we could clearly detect endogenous a-synuclein phosphorylated at Ser-129 in several human cell lines. Thus, in
some tissues and cultured cells, endogenous a-synuclein becomes easily detectable by simply fixing the blotted
membranes. This improved immunoblotting method will allow us to detect previously undetectable endogenous a-
synuclein, thereby facilitating a-synuclein research.
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Introduction
a-Synuclein (a-syn) is a small soluble protein (17 kDa) that
contains 140 amino acids and is predominantly expressed in the
brain. a-Syn localizes to synaptic vesicles and the nucleus—hence
the name ‘‘synuclein’’ [1,2]. Although the exact function of a-syn
is still unclear, substantial evidence now exists to suggest that this
protein is predominantly natively unfolded in solution but can
bind to phospholipid membranes by adopting an a-helical
secondary structure in its N-terminal region [3,4]. In neurons, a-
syn regulates the pool of synaptic vesicles through an interaction
with membranes [2].
Clinically, a-syn is a well-known molecule because mutations
and copy number variation in the a-syn gene have been linked to
Parkinson’s disease (PD) [5,6,7,8]. Furthermore, inclusions
containing a-syn (called Lewy bodies) are pathological hallmarks
of PD [9,10]. PD is the second most common neurodegenerative
disease and is characterized by the loss of dopaminergic neurons in
the substantia nigra. The loss appears to be caused by neuronal
cell death due to toxicity of accumulated a-syn [2]. Thus, a-syn is
a central molecule in understanding the development of PD.
Much effort has been directed toward investigating the a-syn
molecule biochemically as well as immunohistochemically.
However, the application of immunoblotting to analyze the
expression of endogenous a-syn, especially in cultured cells, has
been limited [11]. This is partly because appropriate antibodies
against a-syn have not been available until recently. Second, a-syn
may not be transferred or immobilized efficiently on blotting
membranes. Indeed, many researchers have experienced difficulty
in detecting endogenous a-syn in cultured cells using a
conventional immunoblotting method [11]. Interestingly, a similar
problem was previously reported in immunodetection of human
hemoglobin chains. Recently, however, this problem was solved by
fixing the proteins onto blotted membranes with paraformalde-
hyde (PFA) at low concentration [12]. To improve immunodetec-
tion of endogenous a-syn, we applied this fixation method to our
immunoblotting, resulting in clear and strong detection of
endogenous a-syn. Here, we demonstrate the improved immuno-
detection method and reevaluate the expression levels of
endogenous a-syn in cell lines and tissues. Furthermore, we show
that this method is more suitable to studying the ratio of a-syn
aggregates to its monomers.
Materials and Methods
Cell Lines and Culture Conditions
BJAB and U251MG were generous gifts from Dr. Fred Wang
(Harvard Medical School) and Dr. Yoshiki Saito (M. D. Anderson
Cancer Center), respectively. Other cell lines were purchased from
American Type Culture Collection (Manassas, VA). K562, HL60,
U937, Y79 and BJAB cells were cultured in RPMI 1640 medium
supplemented with 10% fetal calf serum and antibiotics. Other cell
lines were maintained in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal calf serum and antibiotics.
Mouse tissues
Tissue lysates were prepared from C57BL/6J mice, which were
purchased from Jackson Laboratory (Bar Harbor, ME). These
mice were maintained in a facility and program accredited by the
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Animal Care International (AAALAC) with the approval number
A3307-01. The animal use protocol (#BR08-09-103) was
authorized by the Institutional Animal Care and Use Committee
(IACUC) of Georgia Health Sciences University on September 18,
2008.
Immunostaining
Cells were cultured on a coverslip in a 3.5-cm dish. After 24 h,
the cells were fixed in a 4% PFA solution for 20 min, stained with
0.1 mg/ml of 49,6-diamidine-29-phenylindole dihydrochloride
(DAPI; Roche Diagnostics, Indianapolis, IN) for 10 min, and
permeabilized with 0.1% TritonX-100 for 10 min at room
temperature. After blocking with 5% horse serum, the cells were
first labeled with mouse monoclonal anti-a-syn (4D6) antibody
(dilution 1:1,000) overnight at 4uC. After washing, the slides were
labeled with Alexa fluor 488-conjugated anti-mouse IgG (Molec-
ular Probes, Eugene, OR) (dilution 1:1,000) for 1 h at room
temperature. Finally, the slides were analyzed by an Axio Imager
M1 microscope (Zeiss). The localization of a-syn was shown by the
green fluorescence of Alexa fluor 488. The nuclei were shown by
the blue fluorescence of DAPI.
Immunoblotting
Protein samples were treated for 30 min at 50uC in a sample-
treating solution containing 2% SDS and 5% b-mercaptoethanol.
The samples were then loaded onto a 12% or 15% SDS-
polyacrylamide gel (7.068.3 cm 60.75 mm) and electrophoresed
using Mini-Protean Tetra system (Bio-Rad) at 15 mA (current
constant). After electrophoresis, proteins separated on the gel were
transferred onto a methanol-activated PVDF membrane (Im-
mobilon-P, pore size 0.45 mm, Millipore) or a nitrocellulose
membrane (Protran BA85, pore size 0.45 mm, Whatman) for 2 h
using TE22 Mighty Small Transfer system (Hoefer Scientific) at
100 V (voltage constant). The membrane was then treated with or
without phosphate-buffered saline (PBS) containing 0.4% PFA for
30 min at room temperature, followed by blocking for 1 h with 5%
skim milk (Carnation) in Tris-buffered saline containing 0.1%
Tween-20 (TBS-T). The membrane was then incubated for 1 h
with a primary antibody in TBS-T containing 1% skim milk. As
primary antibody, mouse monoclonal anti-a-syn antibodies 4D6
and LB509 (Santa Cruz Biotechnology) and rabbit monoclonal
anti-phospho a-syn antibody EP1536Y (Epitomics, Burlingame,
CA) were used at a dilution 1:1,000, and rabbit polyclonal anti-
actin antibody (Sigma) was also used at a dilution 1:5,000. After
washing with TBS-T containing 1% skim milk for 5 min three
times, the membrane was incubated for 1 h with a secondary
antibody, horseradish peroxidase-conjugated anti-mouse IgG or
anti-rabbit IgG antibody (Santa Cruz Biotechnology), in TBS-T
containing 1% skim milk. After washing with TBS-T for 10 min
three times, protein bands on the membrane were detected by
chemiluminescence method using ECL-Plus immunoblotting
detection system (GE Healthcare).
Generation of a-Syn-knockdown Cell Line
We knocked down endogenous a-syn by RNAi to establish an a-
syn-knockdown cell line of human melanoma SK-MEL28 cells. In
brief, we used lentivirus-mediated RNAi, called MissionH short hairpin
RNA (shRNA) system (Sigma-Aldrich). According to the protocol
provided with the system, lentiviruses were generated and infected to
SK-MEL28 cells. Infected cells were then selected with puromycin.
Recombinant a-Syn Protein
To investigate a-syn monomers and its aggregates, we
purchased recombinant human a-syn protein (Cat. #S7820,
Sigma-Aldrich) that was expressed in E. coli and purified.
Results
Discrepancy between Immunoblotting and
Immunostaining in a-Syn Detection
Although a-syn is predominantly expressed in nervous system
tissues [1], it is difficult to detect endogenous a-syn in cultured cell
lines by immunoblotting. Indeed, we recently demonstrated that
endogenous a-syn is undetectable in human neuroblastoma SH-
SY5Y cells, but detectable in human melanoma cells such as SK-
MEL28 [11]. To further investigate endogenous a-syn, we
performed immunoblotting and immunostaining using 6 human
cell lines: SK-MEL28 (malignant melanoma), SH-SY5Y (neuro-
blastoma), HEK293 (human embryonic kidney cell), HeLa
(cervical adenocarcinoma), HT1080 (lung fibrosarcoma), and
SW620 (colon adenocarcinoma). As shown in Fig. 1A, endogenous
a-syn is detectable only in SK-MEL28, whereas it was undetect-
able in other human cell lines, which is consistent with our recent
report [11].
Next, using an indirect immunofluorescent staining method, we
immunostained endogenous a-syn in the same cell lines with the
same antibody (4D6) at the same dilution. As shown in Fig. 1B,
endogenous a-syn was clearly immunostained in SK-MEL28, SH-
SY5Y, HEK293, and HeLa cells, but not in HT1080 and SW620
cells. The staining was strong in SK-MEL28, SH-SY5Y, and
HEK293 cells, while it was weak in HeLa cells. To confirm these
results, we then immunostained the same cell lines with another
anti-a-syn antibody. The staining results were the same as those of
4D6 (data not shown).
In general, the indirect immunofluorescent staining is not a
highly sensitive method. In our experiments, however, this method
allows us to detect endogenous a-syn more sensitively than
immunoblotting, suggesting that there is an unknown problem in a
conventional method of immunoblotting for a-syn detection.
Improved Method of Immunoblotting for a-Syn
Detection
Previously, Suzuki, et al. reported that human hemoglobin can
be efficiently detected by immunoblotting when blotted mem-
branes are fixed with 0.4% PFA [12]. To improve our method for
a-syn detection, we applied this membrane fixation to our
immunoblotting. First, we performed immunoblotting with or
without membrane fixation to detect endogenous a-syn in 11
human cell lines: SK-MEL28, SH-SY5Y, K562 (erythroleukemia),
HEK293, HeLa, HT1080, HL60 (promyelocytic leukemia), BJAB
(Burkitt’s lymphoma), SW620, U937 (myeloid leukemia), and 786-
0 (renal cell carcinoma). As shown in Fig. 2, when a conventional
method (without membrane fixation) was used, endogenous a-syn
was weakly detected only in SK-MEL28 cells, but not in the others
(see PFA (2)). However, when an immunoblotting method with
membrane fixation was used, endogenous a-syn was strongly
detected in SK-MEL28, SH-SY5Y, HEK293, and HL60 cells (see
PFA (+)). In addition, it was weakly, but clearly, detected in K562
and HeLa cells. Importantly, the expression levels of endogenous
a-syn in SK-MEL28, SH-SY5Y, HEK293, HeLa, HT1080, and
SW620 cells corresponded to those detected by immunostaining
(see Fig. 2 and Fig. 1B).
Immunodetection of a-Synuclein
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in Cell Lines and Tissues
Next, we reevaluated expression levels of endogenous a-syn in
cell lines that we examined in our recent publication [11]. Fig. 3
shows the expression levels of endogenous a-syn in various
melanoma cell lines. Although endogenous a-syn was undetectable
in A375 using a conventional method (see PFA (2)), PFA fixation
allowed us to detect it by 4D6 in all tested cell lines such as human
melanoma SK-MEL28, A375, MeWo, and WM266-4 and mouse
melanoma B16 (see PFA (+)). It should be noted that mouse a-syn
in B16 was detected by 4D6, but not by LB509, which reacts with
human a-syn only [13]. This result suggests that the mouse a-syn
band detected by 4D6 on a PFA-fixed membrane is not a non-
specific band.
Since a-syn is predominantly expressed in the nervous system
[1], we also examined its expression levels in human cell lines
derived from the nervous system, including the retinoblastoma
Y79 cell line and 3 brain tumor cell lines, SH-SY5Y, U251MG
(glioblastoma), and Daoy (medulloblastoma). As shown in Fig. 4,
when a conventional method of immunoblotting was used, the
expression of a-syn was undetectable in the brain tumor and
retinoblastoma cell lines tested (see PFA (2)). In contrast, when the
immunoblot membrane was fixed with PFA, endogenous a-syn
was strongly detected in SH-SY5Y and Daoy cells (see PFA (+)).
As described above, PFA fixation of blotted membranes
dramatically improved the detection of endogenous a-syn in
many cell lines. This dramatic improvement raised the question as
to whether phosphorylated a-syn can be detected in these cell
lines. In Lewy bodies of patients with PD, a-syn is predominantly
phosphorylated at Ser-129 (S129) [9,14], suggesting the impor-
tance of this phosphorylation in disease pathogenesis. Therefore,
the S129 phosphorylation should be investigated using neuronal
cells. Although we have had difficulty in its detection by a
conventional immunoblotting method, we may detect S129-
phosphorylated a-syn by immunoblotting using PFA fixation. To
test this possibility, we performed immunoblotting using protein
samples in which a-syn was detectable in Figs. 2, 3, and 4. As
shown in the middle panels of Fig. 5, EP1536Y antibody detected
S129-phosphorylated a-syn in Daoy, SK-MEL28, MeWo, and
WM266-4 cell lines with membrane fixation, but not in other cell
lines including SH-SY5Y (see PFA (+)). As expected, the
Figure 1. Detection of endogenous a-syn. A,C o n v e n t i o n a l
immunoblotting of various human cell lines. Total cell lysates were
prepared from 6 human cell lines: SK-MEL28 (malignant melanoma), SH-
SY5Y (neuroblastoma), HEK293 (human embryonic kidney cell), HeLa
(cervical adenocarcinoma), HT1080 (lung fibrosarcoma), and SW620
(colon adenocarcinoma). The lysates (3 ml) containing ,10 mg proteins
were loaded per lane onto a 15% SDS-polyacrylamide gel. After SDS-
PAGE and Western transfer onto a PVDF membrane, immunoblotting
was performed using anti-a-syn antibody 4D6 (upper panel). To
demonstrate near equal loading amount of total cell lysates,
immunoblotting using anti-actin antibody was also performed (lower
panel). Molecular size markers are shown in kilodaltons (kDa). B, a-Syn
immunostaining of various human cell lines. The indicated cell lines
were fixed with PFA, stained with DAPI, permeabilized with 0.1%
TritonX-100, and immunostained with mouse monoclonal anti-a-syn
antibody 4D6. After washing, cells were labeled with Alexa Fluor 488-
conjugated goat anti-mouse IgG antibody. The cells were then analyzed
by fluorescence microscopy. The localization of endogenous a-syn is
shown by the green fluorescence of Alexa Fluor 488. Nuclear
counterstaining is shown by the blue fluorescence of DAPI. Scale bar
indicates 10 mm.
doi:10.1371/journal.pone.0023939.g001
Figure 2. Immunoblotting of endogenous a-syn in various
human cell lines. Total cell lysates were prepared from 11 human cell
lines: SK-MEL28 (malignant melanoma), SH-SY5Y (neuroblastoma), K562
(erythroleukemia), HEK293 (human embryonic kidney cell), HeLa
(cervical adenocarcinoma), HT1080 (lung fibrosarcoma), HL60 (promy-
elocytic leukemia), BJAB (Burkitt’s lymphoma), SW620 (colon adenocar-
cinoma), U937 (myeloid leukemia), and 786-0 (renal cell carcinoma). The
protein samples (,10 mg) were loaded onto a 15% SDS-polyacrylamide
gel and electrophoresed, followed by Western transfer onto a PVDF
membrane. The membrane was then fixed with or without 0.4% PFA for
30 min. Afterwards, the membrane was blocked with 5% skim milk and
incubated with a primary antibody such as anti-a-syn antibody 4D6,
anti-a-syn antibody LB509, or anti-actin antibody. The membrane was
then incubated with a secondary antibody conjugated with horseradish
peroxidase. Protein bands on the membrane were detected by ECL-Plus
detection system. Symbols (+) and (2) indicate presence and absence
of membrane fixation with 0.4% PFA, respectively. Molecular size
markers are shown in kilodaltons (kDa).
doi:10.1371/journal.pone.0023939.g002
Immunodetection of a-Synuclein
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blotted membrane without fixation (see PFA (2)).
Finally, we performed immunoblotting using various mouse
tissues. As shown in Fig. 6, endogenous a-syn was detected only in
the cerebellum and cerebrum by a conventional method (PFA
(2)), whereas it was detected in the spleen and kidney in addition
to the cerebellum and cerebrum on a PFA-fixed membrane (see
PFA (+)).
Evidence for Specific Immunodetection of a-Syn on a
PFA-fixed Membrane
In immunostaining with PFA fixation, tissues and cultured cells
are fixed with 4% PFA. Sometimes, however, this fixation
generates non-specific staining. Therefore, although the mem-
brane was fixed with highly diluted PFA (0.4%) in our
immunoblotting, it was possible that the band on the fixed
membrane was non-specific. To rule out this possibility, we used
SK-MEL28 cells in which endogenous a-syn was knocked down
by shRNA. As control, we used SK-MEL28 cells expressing
control shRNA. In brief, we prepared total cell lysates from these
cells and examined the expression levels of a-syn by immunoblot-
ting with or without membrane fixation. As shown in Fig. 7, a-syn
bands were almost undetectable by anti-a-syn antibody LB509
when the membrane was not fixed with PFA (lanes 1 and 2).
However, only a 17-kDa band was strongly detected in the control
SK-MEL28 cells when the membrane was fixed with PFA (lane 3).
As expected, this band almost disappeared in the sample of a-syn-
knockdown SK-MEL28 cells (lane 4). These results suggest that
the 17-kDa band detected on the PFA-fixed membrane represents
endogenous a-syn.
Detachment of a-Syn Monomers from
Western-transferred Membrane
As shown above, detection of endogenous a-syn is dramatically
improved by mild fixation of the blotted membrane with PFA.
There are two possible explanations for this improvement in
detection. One explanation is that the PFA treatment unmasks
epitope(s) of a-syn. The other explanation is that the PFA fixation
effectively immobilizes a-syn on the blotted membrane. In other
words, a-syn easily detaches from the blotted membrane without
PFA fixation. The first explanation is unlikely to be correct
because we used three different monoclonal antibodies (4D6,
LB509, and EP1536Y) that react with distinct epitopes. It is most
unlikely that all three epitopes are unmasked by the PFA
treatment. The second explanation appears to be more likely.
To prove this, we used the same samples shown in Fig. 2 (total cell
lysates of SK-MEL28, SH-SY5Y, and BJAB) and performed
immunoblotting using three different protocols (A, B, and C).
Briefly, in Protocol A, the conventional immunoblotting method
(without PFA fixation) was used. In Protocol B, the membrane was
Figure 3. Immunoblotting of endogenous a-syn in various
melanoma cell lines. Total cell lysates were prepared from 4 human
melanoma cell lines (SK-MEL28, A375, MeWo, and WM266-4) and 1
mouse melanoma cell line (B16). The protein samples (,10 mg) were
loaded onto a 15% SDS-polyacrylamide gel and electrophoresed,
followed by Western transfer onto a PVDF membrane. The membrane
was then fixed with or without 0.4% PFA for 30 min. Afterwards, the
membrane was blocked and incubated with a primary antibody (anti-a-
syn antibody 4D6, anti-human a-syn antibody LB509, or anti-actin
antibody) and a secondary antibody conjugated with horseradish
peroxidase. Protein bands on the membrane were detected by ECL-Plus
detection system. Symbols (+) and (2) indicate presence and absence
of membrane fixation with 0.4% PFA, respectively. Molecular size
markers are shown in kilodaltons (kDa).
doi:10.1371/journal.pone.0023939.g003
Figure 4. Immunoblotting of endogenous a-syn in tumor cell
lines of the head. Total cell lysates were prepared from human
retinoblastoma cell line Y79 and 3 human brain tumor cell lines: SH-
SY5Y (neuroblastoma), U251MG (glioblastoma), and Daoy (medullo-
blastoma). The protein samples (,10 mg) were loaded onto a 15% SDS-
polyacrylamide gel and electrophoresed, followed by Western transfer
onto a PVDF membrane. The membrane was then fixed with or without
0.4% PFA for 30 min. Afterwards, the membrane was blocked and
incubated with a primary antibody (anti-a-syn antibody 4D6, anti-a-syn
antibody LB509, or anti-actin antibody) and a secondary antibody
conjugated with horseradish peroxidase. Protein bands on the
membrane were detected by ECL-Plus detection system. Symbols (+)
and (2) indicate presence and absence of membrane fixation with 0.4%
PFA, respectively. Molecular size markers are shown in kilodaltons (kDa).
doi:10.1371/journal.pone.0023939.g004
Immunodetection of a-Synuclein
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Protocol C, after Western transfer, the membrane was incubated
for 3 h 45 min in TBS-T buffer (to match the incubation time of
Protocol A) and then fixed with 0.4% PFA for 30 min. Afterwards,
these membranes were blocked and incubated with a primary
antibody (anti-a-syn 4D6, LB509, or anti-actin) and a secondary
antibody conjugated with horseradish peroxidase. Protein bands
on the membranes were detected by ECL-Plus detection system.
As shown in Fig. 8, when Protocol A and Protocol B were used,
we had the same results as demonstrated in Fig. 2. In brief,
endogenous a-syn was weakly detected in positive control samples
when the conventional immunoblotting method (Protocol A) was
used. In contrast, the detection of endogenous a-syn was
dramatically improved when the blotted membrane was fixed
with PFA (Protocol B). Importantly, when the blotted membrane
was incubated for 3 h 45 min in TBS-T buffer after Western
transfer (Protocol C), the subsequent PFA fixation was not effective
for the detection of endogenous a-syn. These results suggest that a-
syn monomers detach from the blotted membrane during
incubation when not fixed with PFA.
Immunoblotting of a-Syn using Nitrocellulose
Membranes
PVDF and nitrocellulose are the two membrane types most
commonly used in immunoblotting applications. In the immuno-
blotting experiments described above, we used PVDF membranes
because it was previously reported that they show better protein
retention [15]. However, there was a possibility that a-syn is
detected more strongly on nitrocellulose membranes. To test this
possibility, we performed immunoblotting using both PVDF and
nitrocellulose membranes to detect endogenous a-syn. Specifically,
total cell lysates were prepared from SK-MEL28 (positive control),
SH-SY5Y (positive control), and BJAB (negative control). The
protein samples were electrophoresed, followed by Western
transfer onto a PVDF or nitrocellulose membrane. The membrane
was then fixed with or without 0.4% PFA. Afterwards, endogenous
a-syn was detected using anti-a-syn antibodies 4D6 and LB509. As
shown in Fig. 9, PFA fixation dramatically improved detection of
endogenous a-syn on both PVDF membranes (left panels) and
nitrocellulose membranes (right panels). Importantly, the a-syn
immunoblotting on PVDF membranes showed better detection
than that on nitrocellulose membranes, probably due to better
protein retention.
Detection of Monomers and Aggregates of Recombinant
a-Syn on a PFA-fixed Membrane
a-Syn tends to form aggregates in vivo and in vitro [2]. To
investigate how aggregates and monomers of a-syn are detected on
a PFA-fixed membrane, we performed immunoblotting using
recombinant human a-syn generated and purified from bacteria.
Figure 5. Immunoblotting of endogenous a-syn phosphorylat-
ed at Ser-129 in various human cell lines. Total cell lysates were
prepared from 10 human cell lines: SH-SY5Y (neuroblastoma), K562
(erythroleukemia), HEK293 (human embryonic kidney cell), HeLa
(cervical adenocarcinoma), HL60 (promyelocytic leukemia), Daoy
(medulloblastoma), SK-MEL28 (malignant melanoma), A375 (malignant
melanoma), MeWo (malignant melanoma), and WM266-4 (malignant
melanoma). The protein samples (,10 mg) were loaded onto a 15%
SDS-polyacrylamide gel and electrophoresed, followed by Western
transfer onto a PVDF membrane. The membrane was then fixed with or
without 0.4% PFA for 30 min. Afterwards, the membrane was blocked
and incubated with a primary antibody (anti-a-syn antibody LB509, anti-
phospho-a-syn antibody EP1536Y, or anti-actin antibody) and a
secondary antibody conjugated with horseradish peroxidase. Protein
bands on the membrane were detected by ECL-Plus detection system.
Symbols (+) and (–) indicate presence and absence of membrane
fixation with 0.4% PFA, respectively. Molecular size markers are shown
in kilodaltons (kDa).
doi:10.1371/journal.pone.0023939.g005
Figure 6. Immunoblotting of endogenous a-syn in various
mouse tissues. Tissue lysates were prepared from C57BL/6J mice. The
protein samples (,10 mg) were loaded onto a 15% SDS-polyacrylamide
gel and electrophoresed, followed by Western transfer onto a PVDF
membrane. The membrane was then fixed with or without 0.4% PFA for
30 min. Afterwards, the membrane was blocked and incubated with a
primary antibody (anti-a-syn antibody 4D6 or anti-actin antibody) and a
secondary antibody conjugated with horseradish peroxidase. Protein
bands on the membrane were detected by ECL-Plus detection system.
Symbols (+) and (2) indicate presence and absence of membrane




PLoS ONE | www.plosone.org 5 August 2011 | Volume 6 | Issue 8 | e23939As shown in Fig. 10, when the membrane was not fixed with PFA,
a-syn monomers were not clearly detected, whereas its aggregates
with high molecular weight were strongly detected (lanes 1–4). In
contrast, when the membrane was fixed with PFA, a-syn
monomers were strongly detected in a loading-amount-dependent
manner (lanes 5–8). In lanes 7 and 8, its dimers were also detected.
Importantly, its aggregates on a PFA-fixed membrane (lanes 5-8)
were detected at the same strength as detected on an unfixed
membrane (lanes 1–4). These results suggest that monomers and
dimers of a-syn were detached from the unfixed membrane during
the experimental procedure (lanes 1-4). However, the detachment
appears to be prevented by the PFA fixation (lanes 5–8). a-Syn
aggregates do not seem to be affected seriously by the detachment
problem (lanes 1-4 vs. lanes 5–8).
Discussion
a-Syn is a key molecule in understanding the development of a-
synucleinopathies such as PD, because a-synucleinopathies are
caused by accumulation of a-syn that escapes from proteolytic
cellular clearance [2]. To elucidate the pathogenesis of a-
synucleinopathies, we must use neuronal cell lines to investigate
endogenous a-syn. However, it has been almost undetectable by a
conventional immunoblotting method in many human cell lines
including neuronal cell lines such as SH-SY5Y [11]. This difficulty
in detection of endogenous a-syn has largely restricted progress in
a-synucleinopathy research. In this study, we modified the
immunoblotting method by fixing blotted membranes with PFA,
resulting in dramatic improvement in detection of endogenous a-
syn in human cell lines including SH-SY5Y.
When a conventional immunoblotting method is used, why is
there such difficulty in detection of endogenous a-syn? A clue to
answer this question exists in results of our experiments using
recombinant a-syn that contains monomers and aggregates.
Specifically, our results indicate that a-syn monomers easily detach
from blotted membranes, whereas a-syn aggregates are more stably
immobilized on the blotted membranes. On the basis of these
results, we have concluded that the difficulty in detection of
endogenous a-syn results from the detachment tendency of a-syn
monomers, and is not due to the anti-a-syn antibodies or sensitivity
of immunodetection system. Importantly, the detachment of a-syn
can easily be prevented by the PFA fixation of blotted membranes.
In a-synucleinopathies, a-syn accumulates and forms aggregates
that are toxic to neurons, leading to neurodegeneration [2].
Therefore, many researchers have extensively investigated a-syn
aggregates. In these studies, a conventional immunoblotting
method has frequently been used to compare the expression levels
of the aggregates with those of the monomers. However, our
results imply that, although a-syn aggregates have correctly been
detected in such studies, a-syn monomers have been detected at
much lower levels than the actual expression levels. For example, if
we analyze the recombinant a-syn purchased from Sigma by a
conventional immunoblotting method, we should conclude that
Figure 7. Detection of a-syn knockdown effect by immuno-
blotting using conventional method and improved method. In
SK-MEL28 cells, shRNA of control or a-syn was expressed by lentivirus
infection. Total cell lysates were loaded onto a 15% polyacrylamide gel,
followed by immunoblotting using anti-a-syn antibody LB509 and anti-
actin antibody. PFA (+) and (2) indicate presence and absence of
membrane fixation with 0.4% PFA, respectively. Molecular size markers
are shown in kilodaltons (kDa).
doi:10.1371/journal.pone.0023939.g007
Figure 8. Detachment of a-syn monomers from Western-
transferred membrane. Total cell lysates were prepared from SK-
MEL28 (positive control), SH-SY5Y (positive control), and BJAB (negative
control) cells. The protein samples (,10 mg) were loaded onto a 15%
SDS-polyacrylamide gel and electrophoresed, followed by Western
transfer onto a PVDF membrane. The membrane was then processed
using three different protocols. In Protocol A,t h ec o n v e n t i o n a l
immunoblotting method (without PFA fixation) was used. In Protocol
B, the membrane was fixed with 0.4% PFA for 30 min just after Western
transfer. In Protocol C, the membrane was incubated for 3 h 45 min
(3.75 h) in TBS-T buffer after Western transfer and then fixed with 0.4%
PFA for 30 min. Afterwards, these membranes were blocked and
incubated with a primary antibody (anti-a-syn 4D6, LB509, or anti-actin)
and a secondary antibody conjugated with horseradish peroxidase.
Protein bands on the membranes were detected by ECL-Plus detection
system. Molecular size markers are shown in kilodaltons (kDa).
doi:10.1371/journal.pone.0023939.g008
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interpretation is not correct. In point of fact, a-syn aggregates are
much less than its monomers (see lane 8, Fig. 10). Thus, it is
possible that we have overestimated the extent of aggregate
formation of a-syn in a-synucleinopathy research. However, we
are now able to avoid this detection problem by fixing the blotted
membranes with PFA. This method may be very beneficial to
studies of a-syn aggregates as well as monomers.
a-Syn is predominantly phosphorylated at S129 in Lewy bodies of
PD patients [9,14] and in Lewy body-like inclusions of transgenic mice
expressing human mutant A53T a-syn [16], suggesting the importance
of this phosphorylation in disease pathogenesis. However, a-syn
phosphorylated at S129 constitutes only a very small fraction of soluble
a-syn in the neuron [9,14], which has been a barrier to research of
S129-phosphorylated a- s y n .I nt h i ss t u d y ,u s i n go u rm o d i f i e d
immunoblotting method, we demonstrated that S129-phosphorylated
a-syn is clearly detectable in some human cell lines. Thus, our method
may also enhance research of S129-phosphorylated a-syn.
In conclusion,the PFA fixation ofblotted membranes allowsusto
easily detect a-syn monomers (even their phosphorylated form) in
cell lines and mouse tissues. This innovative modification in
immunoblotting for a-syn will enhance progress in a-syn biology.
In a-synucleinopathyresearch, however, a-syn in samples of human
patients and PD model mice might act differently than a-syn in the
samplespresentedhere.Furtherstudieswillberequiredtoapplyour
modified immunoblotting method to such pathological conditions.
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